Operational Aspects of Data Monitoring Committees

May 26, 2011

IDDI organized a webinar on Operational Aspects of Data Monitoring Committees.

The webinar explored best practices that have emerged during this time. The emphasis was on the safety monitoring responsibilities of data monitoring committees in the pharma industry.

  • The webinar showed how practices and issues vary over these three strata. Organizational issues, meetings, clinical issues, useful statistical methods, biases and pitfalls, DMC decisions and emerging issues including adaptive designs and cost control were covered. The issues were illustrated by actual behind-the-scenes scenarios providing rare look at DMC practices.
  • Speaker:
    • Dr. Jay Herson, Senior Associate, Biostatistics, Johns Hopkins University Baltimore, Maryland USA. Dr. Herson, a collaborator of IDDI, will draw on his 25-year experience with data monitoring committees (DMC) in the pharmaceutical industry which led to his book Data and Safety Monitoring Committees in Clinical Trials published by Chapman and Hall/CRC in 2009

VIEW THE RECORDING OF THE WEBINAR HERE

TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL OUT THE FORM BELOW

Presentation of the Webinar : Operational Aspects of Data Monitoring Committees

To access the presentation of this on-demand webinar, please fill out this form.

By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

I authorize IDDI to use my data to contact me for commercial purposes. More information
Powered by Atypic ®

IDDI